ChiLin: a comprehensive ChIP-seq and DNase-seq quality control and analysis pipeline
Qian Qin(Broad Institute), X. Shirley Liu(Harbin Medical University), Shenglin Mei(Harvard University), Yong Zhang(Shanghai East Hospital), Chongzhi Zang(University of Virginia Cancer Center), Qiu Wu(Shanghai Pulmonary Hospital), Hanfei Sun(Tongji University), Clifford A. Meyer(Dana-Farber Cancer Institute), Lewyn Li(Dana-Farber Cancer Institute), Myles Brown(Harvard University), Len Taing(Dana-Farber Cancer Institute), Henry W. Long(Dana-Farber Cancer Institute), Tao Liu(PowerChina (China)), Yiwen Chen(The University of Texas MD Anderson Cancer Center), Fugen Li(Precision for Medicine (United States)), Han Xu(The University of Texas MD Anderson Cancer Center), Sujun Chen(Ontario Institute for Cancer Research)
Cited by 144
Related Papers
Model-based Analysis of ChIP-Seq (MACS)
|Genome biology|2008|20k
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
|Genome biology|2016|2.8k
Identifying ChIP-seq enrichment using MACS
|Nature Protocols|2012|2.1k
The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors
|Journal of Clinical Investigation|2011|928
Cistrome: an integrative platform for transcriptional regulation studies
|Genome biology|2011|792